ION464

· Ionis Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ION464, covering 2026-04-07 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ION464 Administered to Adults With Multiple System Atrophy (HORIZON) [Phase 1]

See pricing